What is Tysabri (and what “biologic” means here)?
Tysabri is a biologic medicine: a drug made from living cells or produced using biotechnology rather than as a simple chemical. Tysabri contains the monoclonal antibody natalizumab, which targets immune-cell trafficking to reduce inflammation in certain autoimmune diseases. [1]
What conditions does Tysabri treat?
Tysabri is used for:
- Relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome in some cases, to reduce the frequency of relapses. [1]
- Moderate to severe Crohn’s disease in adults who have had an inadequate response to other therapies. [1]
How does Tysabri work as an immune-targeting biologic?
Natalizumab binds to alpha-4 integrin, helping block the movement of immune cells from the blood into the brain or intestines. By limiting that migration, it can reduce inflammation and the symptoms caused by it. [1]
How is Tysabri given?
Tysabri is administered as an infusion (it is not a pill). Patients typically receive it on a regular schedule through an infusion clinic or hospital setting. [1]
What safety issue is patients most concerned about (risk of PML)?
A key risk associated with natalizumab is progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection. Risk is tied to factors such as prior use of immunosuppressant medicines and whether a specific JC virus blood test is positive, and the risk can increase with longer treatment exposure. [1]
What monitoring is usually done during treatment?
Because of PML risk, clinicians use monitoring strategies that commonly include:
- JC virus antibody testing to assess baseline risk
- Ongoing risk assessment over time
- Careful evaluation of new neurologic symptoms while on therapy [1]
Is Tysabri a “biologic” like biosimilars and other monoclonal antibodies?
Yes. Tysabri is a monoclonal antibody biologic, which is why it falls into the same general category of treatments as other antibody-based biologics used in MS and inflammatory diseases. Whether a biosimilar exists for a specific brand depends on patent and regulatory status, but Tysabri itself is a branded biologic therapy based on natalizumab. [1]
Where can you verify the exact product details?
The most reliable references for drug identity, indications, dosing/administration, and boxed or major safety information are the official prescribing information and regulator-approved labeling. [1]
Sources
[1] https://www.tysabri.com/